Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze OCUL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate OCUL investment potential.

What is OCUL stock price today?

Get real-time OCUL stock price, historical data, and price charts on Financhill. Track OCUL performance with our advanced analysis tools.

Is OCUL a good investment?

Evaluate OCUL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy OCUL stock?

To buy OCUL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of OCUL?

View detailed market capitalization data and company valuation metrics for OCUL on our comprehensive analysis page.

What is the P/E ratio of OCUL?

Use our fundamental analysis tools to view OCUL P/E ratio and compare valuation metrics with industry peers.

What are OCUL earnings?

View OCUL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Ocular Therapeutix, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

OCUL
Ocular Therapeutix, Inc.

Last Price:

$12.54

Seasonality Move:

31.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Ocular Therapeutix, Inc. Stock Forecast

Over the next 52 weeks, Ocular Therapeutix, Inc. has on average historically risen by 38% based on the past 11 years of stock performance.
Ocular Therapeutix, Inc. has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Is Ocular Therapeutix, Inc. Stock Undervalued?

The current Ocular Therapeutix, Inc. [OCUL] share price is $12.56. The Score for OCUL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
OCUL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Ocular Therapeutix, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Ocular Therapeutix, Inc. has on average historically risen by 38% based on the past 11 years of stock performance.

Ocular Therapeutix, Inc. Stock Rating

Buy

Ocular Therapeutix, Inc. (OCUL) is a Buy

Is Ocular Therapeutix, Inc. overpriced?

Ocular Therapeutix, Inc. has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%

Ocular Therapeutix, Inc. Stock Price History

Is OCUL stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCUL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

ocutx.com

52-Week Data

52-Week High:

16.44

52-Week Low:

5.79

Prediction Charts

Market Cap:

2.7B

Price in USD:

12.56

Volume:

Beta:

1.50

Technical Analysis

SMA50:

12.20

SMA100:

12.23

SMA200:

10.36

52-Wk Change:

48.64%

Stock Predictions

Is Ocular Therapeutix, Inc. stock public?

Yes, Ocular Therapeutix, Inc. is a publicly traded company.
What is the Ocular Therapeutix, Inc. stock quote today?

The Ocular Therapeutix, Inc. stock price is 12.56 USD today.
How to buy Ocular Therapeutix, Inc. stock online?

You can buy Ocular Therapeutix, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-2	11.70	11.25	11.80	11.15
Dec-3	11.25	11.46	11.57	11.17
Dec-4	11.48	12.43	13.00	11.41
Dec-5	12.49	12.58	12.69	12.35
Dec-8	14.58	16.11	16.44	14.58
Dec-9	16.12	15.95	16.31	15.57
Dec-10	16.06	15.41	16.14	15.31
Dec-11	15.40	14.67	15.57	14.55
Dec-12	14.83	14.56	15.38	14.35
Dec-15	14.63	14.17	14.85	14.13
Dec-16	14.12	14.39	14.53	14.12
Dec-17	14.35	13.72	14.64	13.59
Dec-18	13.87	12.98	13.91	12.95
Dec-19	12.99	12.56	13.21	12.27

Ocular Therapeutix, Inc. Earnings

Ocular Therapeutix, Inc. Earnings Report: Per Share Ocular Therapeutix, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ocular Therapeutix, Inc. Forecast Revenue Growth

Ocular Therapeutix, Inc. Stock Analysis: Historical quarterly revenues per share for Ocular Therapeutix, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.05 per share.

* Ocular Therapeutix, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.